Cisen Pharmaceutical Co., Ltd. provided earnings guidance for the third quarter of 2018. Foe the quarter, the company expected net profit owned by shareholders of the listed company in the 3rd quarter of 2018 to be between RMB 346,967,800 and RMB 387,787,500, with an increase of between RMB 142,869,100 and RMB 183,688,800 compared with the same period of the year before and a year-on-year increase of between 70% and 90%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 336,567,800 and RMB 373,964,300, with an increase of between RMB 149,585,700 and RMB 186,982,100 compared with the same period of the year before, and a year-on-year increase of between 80% and 100%.